The effect of cyclic adenosine- and guanosine 3',5'-monophosphate on the normal and drug-increased coronary blood flow.
D000241:Adenosine / Q000494:pharmacology; D000818:Animals; D001011:Aorta / Q000187:drug effects; D001593:Benzyl Compounds / Q000494:pharmacology; D001783:Blood Flow Velocity; D001794:Blood Pressure / Q000187:drug effects; D003326:Coronary Circulation / Q000187:drug effects*; D000242:Cyclic AMP / Q000494:pharmacology*; D006152:Cyclic GMP / Q000494:pharmacology*; D004285:Dogs; D004837:Epinephrine / Q000494:pharmacology; D050356:Lipid Metabolism; D009130:Muscle, Smooth / Q000187:drug effects; D013806:Theophylline / Q000494:pharmacology; D014665:Vasodilator Agents / Q000494:pharmacology
D001593:Benzyl Compounds; D014665:Vasodilator Agents; D013806:Theophylline; D000242:Cyclic AMP; D006152:Cyclic GMP; D000241:Adenosine; D004837:Epinephrine